指南与共识妇产影像儿科影像神经USMR

胎儿胼胝体异常的产前评估、诊断与管理:国际德尔菲共识

Prenatal evaluation, diagnosis and management of fetal corpus callosal abnormalities: international Delphi consensus.
指南 / 共识 · Ultrasound Obstet Gynecol · 2025-08-23

该国际德尔菲共识通过三轮专家咨询(首轮55名专家,43名完成全程)形成胎儿胼胝体异常产前评估、诊断与管理的推荐框架,涵盖筛查切面、诊断性超声与MRI应用、遗传与感染病因检查等共识条目,并指出需进一步前瞻性研究验证。

要点

  • 常规超声筛查应获取胎儿大脑矢状切面(72.4%同意),怀疑异常时不要求测量而应转诊专科(100%同意)。
  • 诊断性超声推荐三维超声(72.4%同意)与经阴道超声(82.8%同意),主观感觉大小异常时靶向测量胼胝体长度(82.8%同意)。
  • 疑似胼胝体发育不良应提供侵入性遗传学检查与MRI(100%同意),胼胝体过短、过薄、过厚时应行MRI。

核心结论

  • 该共识为胎儿胼胝体异常的评估与管理提供了结构化框架,旨在通过标准化影像与管理方法提高诊断准确性、优化患者结局并减少不必要干预;需进一步前瞻性研究验证这些推荐并评估其对临床照护的影响。

研究设计与样本

  • 国际德尔菲共识,由国际胎儿医学专家组参与,基于临床专长与发表记录遴选专家;通过专家意见与范围综述制定结构化声明,经三轮迭代评分(前两轮采用五点Likert量表),最终轮以>70%同意定义为共识;首轮55名专家参与,43名(78.2%)完成全程。

关键影像表现/征象

  • 常规超声筛查中应纳入获取胎儿大脑矢状切面(72.4%同意)。
  • 怀疑胼胝体异常时不要求进行测量(93.1%同意),而应转诊至专科(100%同意)。
  • 诊断性超声推荐三维超声成像(72.4%同意)与经阴道超声评估(82.8%同意)。
  • 主观感觉胼胝体大小异常时推荐靶向测量胼胝体长度(82.8%同意)。
  • 对于胼胝体回声不均匀且孤立的病例,推荐进行感染相关检查(86.2%同意)。

诊断标准与关键数值

  • 专家组就用于定义胼胝体长度异常的参考图表未达成共识(86.2%同意存在此无共识状态)。
  • 专家组就用于定义胼胝体长度异常的截断值未达成共识(89.3%同意存在此无共识状态)。
  • 疑似胼胝体发育不良时应提供侵入性遗传学检查与MRI(100%同意)。
  • 胼胝体表现过短(100%同意)、过薄(100%同意)或过厚(92.0%同意)时应行MRI。

临床应用与阅片要点

  • 常规超声筛查应获取胎儿大脑矢状切面,怀疑异常时不测量而应转诊至专科。
  • 诊断性超声可采用三维超声成像与经阴道超声评估,主观感觉大小异常时靶向测量胼胝体长度。
  • 疑似胼胝体发育不良时应提供侵入性遗传学检查与MRI。
  • 胼胝体过短、过薄或过厚时应行MRI。
  • 孤立的胼胝体回声不均匀时推荐进行感染相关检查。

局限性

  • 需进一步前瞻性研究验证这些推荐并评估其对临床照护的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The corpus callosum (CC) is an interhemispheric structure that facilitates communication between the two cerebral hemispheres. Anomalies of the CC are frequent and associated with a wide spectrum of altered neurodevelopmental outcomes. However, variability in diagnostic criteria and the lack of standardized management strategies create challenges for clinicians and anxiety for expectant parents. This study aimed to establish an international consensus on the prenatal evaluation, diagnosis and management of fetal CC abnormalities using a structured Delphi methodology.

METHODS: A three-round Delphi process was conducted among an international panel of fetal medicine experts, identified based on clinical expertise and publication history. Structured statements regarding CC evaluation, diagnosis and management were developed through expert input and a scoping literature review. The statements were iteratively refined and scored by the panel using a five-point Likert scale in the first two rounds. During the final round, consensus was defined as > 70% agreement among participants.

RESULTS: Fifty-five experts participated in the first round, with 43 (78.2%) experts completing the entire process. Key consensus findings included the incorporation of obtaining a sagittal view of the brain in routine ultrasound screening (72.4% agreement), without requiring measurement even when an anomaly is suspected (93.1% agreement), but instead with recommended referral to a specialist (100% agreement). For diagnostic ultrasound, three-dimensional ultrasound imaging (72.4% agreement) and transvaginal ultrasound evaluation (82.8% agreement) were recommended, with targeted measurements of CC length in the case of a subjective impression of abnormal size (82.8% agreement). However, it was agreed that there is no consensus on the reference chart or cut-off values to be used for defining abnormal CC length (86.2% and 89.3% agreement, respectively). In terms of management, it was agreed that both an invasive genetic workup and magnetic resonance imaging (MRI) should be offered in case of suspected dysgenesis of the CC (100% agreement). MRI should be performed if the CC appears to be too short (100% agreement), thin (100% agreement) or thick (92.0% agreement). In the case of an isolated CC with heterogeneous echogenicity, an infectious workup is recommended (86.2% agreement).

CONCLUSION: This study provides a structured framework for the evaluation and management of fetal CC abnormalities. By standardizing approaches to imaging and management, the recommendations aim to improve diagnostic accuracy, optimize patient outcomes and reduce unnecessary interventions. Further prospective studies are needed to validate these recommendations and assess their impact on clinical care. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Corroenne R, Paladini D, Papastefanou I, et al. Prenatal evaluation, diagnosis and management of fetal corpus callosal abnormalities: international Delphi consensus. Ultrasound Obstet Gynecol. 2025. PMID: 40847729. doi:10.1002/uog.70003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。